Navigation Links
MiMedx Group, Inc. Adds Parker H. 'Pete' Petit as Chairman of the Board of Directors, President, and Chief Executive Officer
Date:2/25/2009

ATLANTA, Feb. 25 /PRNewswire-FirstCall/ -- The Board of Directors of MiMedx Group, Inc. (OTC Bulletin Board: MDXG) (the "Company") is pleased to announce the appointment of Parker H. "Pete" Petit as its Chairman of the Board of Directors, President, and Chief Executive Officer, effective February 24, 2009. Mr. Steve Gorlin, who formerly held the position of Chairman, will remain on the Board. Mr. Andrew K. "Kreamer" Rooke, Jr., was appointed to the Board of Directors effective February 24, 2009. Mr. Rooke, who holds a Bachelor's Degree in Economics from the University of Pennsylvania, was an initial investor with the Company and formerly worked directly with the Chairman, advising on the acquisition of SpineMedica Corp. and aiding in the Company's emergence into the public markets. Mr. Thomas W. D'Alonzo, who formerly held the position of CEO, has resigned from his position as CEO and member of the Board of Directors.

Most recently, Mr. Petit was Chairman and CEO of Matria Healthcare which was sold to Inverness Medical Innovations in May of 2008. Matria Healthcare was a former subsidiary of Healthdyne, which Mr. Petit founded in 1971. Mr. Petit served as Chairman and CEO of Healthdyne and some of its publicly traded subsidiaries after Healthdyne became a publicly traded company in 1981. One of Healthdyne's other subsidiaries, was merged with Respironics in 1995, and Respironics was sold in 2008 to Phillips Healthcare. Mr. Petit received his bachelor's degree in Mechanical Engineering and Master of Science degree in Engineering Mechanics from Georgia Tech and an MBA degree in Finance from Georgia State University.

At Georgia Tech, Mr. Petit funded a professorial chair for "Engineering in Medicine", endowed the Petit Institute for Bioengineering and Bioscience, and assisted with the funding of the Biotechnology Building which bears his name. At Georgia State University
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
2. The Ensign Group, Inc. Reports Fourth Quarter 2008 Earnings of $0.38 per Share; Issues 2009 Guidance
3. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
4. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
5. PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009
6. VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia
7. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. SOKO Fitness & Spa Group, Inc. Announces Participation in the ICR XChange Conference
11. The Ensign Group, Inc. Acquires Utah Skilled Nursing Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... 1 With employee benefit...f employers are providing self-service decision-ma...n, according to a new survey by Watson Wyatt, a le...ers who offer these tools believe they lead employ... According to the survey, 45 percent of companies ...
(Date:12/1/2009)...Dec. 1 On December 31, ...federal prisoners were HIV positive or had confirm... the Office of Justice Programs, U.S. Department o...timated 5,672 inmates in state and federal prisons...007, about 43 per 10,000 prison inmates were estim...
(Date:12/1/2009)... and South America, study finds , , TUES...f intensive care unit patients worldwide suffer in...e hospital, a new study finds. , Researchers an...) on 13,796 patients, aged 18 and older, in 1,265 ...f patients were classified as infected and 71 perc...
(Date:12/1/2009)...2009) Wistar Institute researchers and collaborat...rk University have identified immune system marker...ors in people at high risk for developing lung can... Cancer Research , a journal of the American Assoc... blood test to detect lung cancer in its earliest ...
(Date:12/1/2009)...GLE PARK, N.C., Dec. 1 Max Neeman ...expanded over the years serving the top most pharm...as originally set up in an area of 2000 sq. ft. ha...of the suite of services by Max Neeman, are recogn...ffering. ,, The pharmacy inventory management p...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3
...elieve they eat a lot of meat because of the taste...the Journal of Consumer Research, the reason tha... to some people has more to do with values than ac...r Food Industries and Management, France) conducte...
...called a primary stumbling block , , THURS...care in the United States continues to elude more ...ore, since the first "scorecard" was done in 2006,...on. , These are some of the findings in the Common...
...vest Products,Inc. (OTC Bulletin Board: FRHV.OB) a...its long standing commitment to providing consumer...ings, through a new initiative to,build natural an...lieve that this new initiative is a natural and lo...
... Digital Documents, a,provider of turnkey, cost-ef...d HCAHPS Surveys, announced today the integration ... Health Systems, the largest,not-for-profit Protes...e expensive," commented Bruce,Genger, President of...
...January 2, 2009 -, LAVAL, QC, July 17 /PRNewswire...SS) today announced that the response that it subm...A) on July 2, 2008, including the,additional analy...cription Drug User Fee Act (PDUFA) is January 2, 2...
...IGNA, the health service company, launched its new...ents in the Wall Street Journal. Supported by Dore...gn will be the largest in CIGNA's history, an... Philadelphia, PA (PRWEB) July 1...
Other Medicine News:Health News:Good news for veggies 2Health News:U.S. Health Care Still Ill, Survey Finds 2Health News:U.S. Health Care Still Ill, Survey Finds 3Health News:Fresh Harvest Products, Inc. Announces New Brand Initiative 2Health News:Innovative HCAHPS Patient Satisfaction Survey Solution Generates Huge Cost-Savings Opportunity for Adventist Health Systems 2Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 3
(Date:12/1/2009)...TER, N.J., Dec. 1 Tibotec Therapeu...s, L.P., announced today that it is launching a ne...g women and people of color living with HIV/AIDS. ...ducational events, media outreach and a new Web si...g learnings from the GRACE study, the largest clin...
(Date:12/1/2009)...D CITY, Calif., Dec. 1 Codexis, In...p and the signing of its second agreement this yea...rld,s largest generic drug manufacturer. The new ...products. Codexis announced an earlier agreement ...ent, Teva will use Codexis biocatalysis technology...
(Date:12/1/2009)...STON, Dec. 1 An expert f...XL ), a leading global biopharmaceutical services ...ve approaches to drug development in Asia at the P...ence, being held December 1-3, 2009 at the Interco... of the conference, which is focused on maximizing...
Breaking Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 1R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 8Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
...ogentus Pharmaceuticals,Inc. today announced that ...e full antiplatelet activity of its novel combinat...psule that combines clopidogrel (currently,markete...s Plavix(R)) with,a gastroprotectant (omeprazole) ...elet therapy., (Logo: http://www.newscom.com/cgi...
...fety Profile and Favorable Pharmacokinetics ... TRIANGLE PARK, N.C., Jan. 16 CeNeRx BioPharma,In...cializing innovative,treatments for diseases of th...essful completion of the Phase l clinical program ...nt of depression and anxiety. Tyrima is a,selectiv...
Other Medicine Technology:Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168 2CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 2CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 3
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: